These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Comparative study of the antiviral activity of rimantadine and bonafton].
    Author: Il'enko VI, Platonov VG, Khomenkova IK.
    Journal: Vopr Virusol; 1977; (2):223-8. PubMed ID: 898899.
    Abstract:
    The results of the study on toxicity and the antiviral activity of bonaphthone and rimantadine are presented. A high toxicity of bonaphthone for developing chick embryos was demonstrated, the maximum non-toxic dose of bonaphthone being about 10 microgram/embryo, while for rimantadine it was above 1000 microgram/embryo. In white mice, however, the toxicity of these two drugs was approximately similar. The minimal single lethal dose for mice by the oral route was 400-500 mg/kg for rimantadine and bonaphthone, by the intraperitoneal route 65 mg/kg for bonaphthone and 125 mg/kg for rimantadine. Bonaphthone had a slight prophylactic activity protecting mice inoculated with A2/Bethesda/63 influenza virus. The index of effectiveness of bonaphthone was about 40%, that of rimantadine under similar experimental conditions over 90%. Bonaphthone had no therapeutic effect. It inhibited multiplication of A2/Hong Kong/68 influenza virus in the lungs of mice inoculated with minimal doses of the virus, but was inactive in case of infection of mice with A/Port Chalmers/73 virus. Thus, the comparative study of bonaphthone and rimantadine revealed no superiority of bonaphthone.
    [Abstract] [Full Text] [Related] [New Search]